Akebia Therapeutics
AKBA
AKBA
170 hedge funds and large institutions have $141M invested in Akebia Therapeutics in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 41 increasing their positions, 53 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
23% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 53
26% less capital invested
Capital invested by funds: $190M → $141M (-$48.9M)
Holders
170
Holding in Top 10
–
Calls
$933K
Puts
$557K
Top Buyers
| 1 | +$1.66M | |
| 2 | +$1.57M | |
| 3 | +$1.05M | |
| 4 |
Millennium Management
New York
|
+$1M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
+$786K |
Top Sellers
| 1 | -$4.5M | |
| 2 | -$2.85M | |
| 3 | -$2.42M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.08M |
| 5 |
Goldman Sachs
New York
|
-$1.52M |
